JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martínez, V.
Right arrow Articles by Taché, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martínez, V.
Right arrow Articles by Taché, Y.

Vol. 280, Issue 2, 754-760, 1997

Central Injection of a New Corticotropin-Releasing Factor (CRF) Antagonist, Astressin, Blocks CRF- and Stress-Related Alterations of Gastric and Colonic Motor Function1

Vicente Martínez, Jean Rivier2, Lixin Wang and Yvette Taché

CURE: Digestive Diseases Research Center, West Los Angeles VA Medical Center, Department of Medicine and Brain Research Institute, UCLA School of Medicine, Los Angeles, California

The influence of central injection of a new corticotropin releasing factor (CRF) antagonist, astressin, {cyclo(30-33)[D-Phe12,Nle21,38,Glu30,Lys33]r/hCRF12-41)}, on exogenous and endogenous CRF-induced gastric ileus and stimulation of bowel discharges was investigated in conscious rats. Intracisternal (ic) CRF (0.6 µg) reduced gastric emptying of a noncaloric solution to 17.1 ± 4.9% compared with 50.1 ± 4.6% in control group injected ic with vehicle. Astressin (1, 3 and 10 µg, ic) dose dependently prevented ic CRF-induced delayed gastric emptying by 33, 100 and 100%, respectively, and had no effect on basal gastric emptying. Abdominal surgery with cecal manipulation (1 min) reduced gastric emptying to 19.8 ± 5.5% 3 hr postsurgery compared with 59.9 ± 5.2% after anesthesia alone plus ic vehicle. Astressin (1, 3 and 10 µg, ic) prevented postoperative gastric ileus by 56, 93 and 92%, respectively. Intracerebroventricular CRF (0.6 µg) and water-avoidance stress stimulated pellet output (number/60 min) to 5 ± 1 and 11 ± 2, respectively, compared with no fecal pellet output after icv vehicle and no exposure to stress. Astressin (3 and 10 µg, icv) blocked exogenous CRF action by 47 and 63%, respectively, and colonic response to stress by 0 and 54%, respectively. These data indicate that astressin injected into the CSF at low doses (1-10 µg) has an antagonistic action against CRF and stress-related alterations of gastrointestinal motor function, without an intrinsic effect in these in vivo systems. Astressin may be a useful tool to explore functional CRF-dependent physiological pathways in specific brain nuclei.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Larauche, G. Gourcerol, L. Wang, K. Pambukchian, S. Brunnhuber, D. W. Adelson, J. Rivier, M. Million, and Y. Tache
Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G215 - G227.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. R. Miragaya and R. B. S. Harris
Antagonism of corticotrophin-releasing factor receptors in the fourth ventricle modifies responses to mild but not restraint stress
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R404 - R416.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Czimmer, M. Million, and Y. Tache
Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats
Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G511 - G518.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Y Sagami, Y Shimada, J Tayama, T Nomura, M Satake, Y Endo, T Shoji, K Karahashi, M Hongo, and S Fukudo
Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome
Gut, July 1, 2004; 53(7): 958 - 964.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
V. Martinez, L. Wang, J. Rivier, D. Grigoriadis, and Y. Tache
Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice
J. Physiol., April 1, 2004; 556(1): 221 - 234.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Huang, X. Pang, K. Karalis, and T. C. Theoharides
Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in Apolipoprotein E knockout mice
Cardiovasc Res, July 1, 2003; 59(1): 241 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. W Lewis, G. E Hermann, R. C Rogers, and R A. Travagli
In vitro and in vivo analysis of the effects of corticotropin releasing factor on rat dorsal vagal complex
J. Physiol., August 15, 2002; 543(1): 135 - 146.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F.-C. Chang and M. R. Opp
Role of corticotropin-releasing hormone in stressor-induced alterations of sleep in rat
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R400 - R407.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Mertz
Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans
Gut, July 1, 2002; 51(90001): i29 - 33.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Kojima, Y. Naruse, N. Iijima, N. Wakabayashi, S. Mitsufuji, Y. Ibata, and M. Tanaka
HPA-axis responses during experimental colitis in the rat
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2002; 282(5): R1348 - R1355.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Li, J. Vaughan, P. E. Sawchenko, and W. W. Vale
Urocortin III-Immunoreactive Projections in Rat Brain: Partial Overlap with Sites of Type 2 Corticotrophin-Releasing Factor Receptor Expression
J. Neurosci., February 1, 2002; 22(3): 991 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Kihara, M. Fujimura, I. Yamamoto, E. Itoh, A. Inui, and M. Fujimiya
Effects of central and peripheral urocortin on fed and fasted gastroduodenal motor activity in conscious rats
Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G406 - G419.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
E A MAYER
The neurobiology of stress and gastrointestinal disease
Gut, December 1, 2000; 47(6): 861 - 869.
[Full Text] [PDF]


Home page
GutHome page
J Jones, J Boorman, P Cann, A Forbes, J Gomborone, K Heaton, P Hungin, D Kumar, G Libby, R Spiller, et al.
British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome
Gut, November 1, 2000; 47(90002): ii1 - 19.
[Full Text] [PDF]


Home page
Cancer Res.Home page
A. Inui
Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key?
Cancer Res., September 1, 1999; 59(18): 4493 - 4501.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Martínez, J. Rivier, and Y. Taché
Peripheral Injection of a New Corticotropin-Releasing Factor (CRF) Antagonist, Astressin, Blocks Peripheral CRF- and Abdominal Surgery-Induced Delayed Gastric Emptying in Rats
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 629 - 634.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Nozu, V. Martinez, J. Rivier, and Y. Tache
Peripheral urocortin delays gastric emptying: role of CRF receptor 2
Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G867 - G874.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Million, Y. Tache, and P. Anton
Susceptibility of Lewis and Fischer rats to stress-induced worsening of TNB-colitis: protective role of brain CRF
Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G1027 - G1036.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. K. Singh, W. Boucher, X. Pang, R. Letourneau, D. Seretakis, M. Green, and T. C. Theoharides
Potent Mast Cell Degranulation and Vascular Permeability Triggered by Urocortin Through Activation of Corticotropin-Releasing Hormone Receptors
J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1349 - 1356.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F.-C. Chang and M. R. Opp
Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1998; 275(3): R793 - R802.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
V. Martinez, E. Barquist, J. Rivier, and Y. Tache
Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors
Am J Physiol Gastrointest Liver Physiol, May 1, 1998; 274(5): G965 - G970.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. MartInez, F. Cuttitta, and Y. Tache
Central Action of Adrenomedullin to Inhibit Gastric Emptying in Rats
Endocrinology, September 1, 1997; 138(9): 3749 - 3755.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. V. Coutinho, P. M. Plotsky, M. Sablad, J. C. Miller, H. Zhou, A. I Bayati, J. A. McRoberts, and E. A. Mayer
Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat
Am J Physiol Gastrointest Liver Physiol, February 1, 2002; 282(2): G307 - G316.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.